Skip to main content

Table 1 Demographic data for women randomized to oral or vaginal metronidazole.

From: Comparison of oral and vaginal metronidazole for treatment of bacterial vaginosis in pregnancy: impact on fastidious bacteria

 

Oral treatment

(n = 30)

Vaginal treatment

(n = 23)

P valuea

Age (mean years)

23

20

.17

Raceb

  

< .01

   White

7 (20%)

7 (30%)

 

   African American

13 (43%)

4 (17%)

 

   Asian/PI

10 (33%)

4 (17%)

 

   Hispanic

0

7 (30%)

 

Marital statusc

  

.60

   Single

12 (40%)

8 (35%)

 

   Married/living with

17 (57%)

15 (65%)

 

Occupationc

  

.65

   Student

7 (23%)

8 (35%)

 

   Employed

13 (43%)

8 (35%)

 

   Unemployed

10 (33%)

7 (30%)

 

Education (highest completed)c

  

.20

   Primary

9 (30%)

10 (43%)

 

   Secondary

12 (40%)

4 (17%)

 

   Tertiary

9 (30%)

9 (39%)

 

History of douching

6 (20%)

2 (9%)

.44

Smoker

11 (37%)

11 (48%)

.41

Gravidity (median)

2

1

.02

Gestational age at enrollment (median in weeks)

15

16

.51

Gestational age at delivery (median in weeks)

39

40

.78

Birthweight (mean in grams)

3160.5

3203

.94

Clinical cure after treatment

(ie. 0 Amsel's criteria)

17 (57%)

14 (61%)

.73

Microbiologic cure after treatment (ie. Nugent score ≤ 3)

16 (53%)

12 (52%)

.58

  1. aCategorical variables were analyzed using Chi square or Fisher's exact test. Continuous variables were analyzed using the Mann-Whitney U test.
  2. bPercentages may not add up to 100% because of rounding, or missing data points
  3. cMissing data for some participants